P/E at 65.34 vs Industry's 66.24: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: A Near-Industry P/E Reflecting Sector Confidence

The current P/E of 65.34 for Apollo Hospitals Enterprise Ltd. sits just below the hospital industry average of 66.24, indicating that the stock is trading at a valuation level consistent with its peers. This near-parity suggests that investors are pricing in growth prospects and sector-specific risks in a balanced manner. The premium is modest, especially when compared to other large-cap healthcare stocks that often trade at wider valuation gaps. This alignment may reflect the company’s steady earnings growth and market leadership within the hospital sector.

Given the sector’s overall valuation, Apollo Hospitals Enterprise Ltd. does not appear to be overextended on a price basis — previously rated Hold, what is Apollo Hospitals’ current rating? The P/E ratio’s proximity to the industry average invites a closer look at performance metrics to understand if the valuation is justified.

Performance Across Timeframes: Strong Long-Term Gains with Robust Recent Momentum

Examining returns over multiple periods reveals a compelling performance story. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a 20.77% gain, significantly outperforming the Sensex’s decline of 5.69% during the same period. This outperformance extends to the year-to-date figure, where the stock has risen 25.96% compared to the Sensex’s 8.96% loss.

Shorter-term momentum is equally impressive, with a three-month return of 15.22% versus the Sensex’s negative 1.16%. The one-month gain of 5.20% and the one-week rise of 0.33% further underscore the stock’s resilience. However, the one-day performance shows a slight dip of 0.17%, marginally underperforming the Sensex’s 0.51% gain. This minor intraday weakness is unlikely to alter the broader trend but highlights the stock’s sensitivity to daily market fluctuations.

Longer-term returns are even more striking. Over three years, the stock has appreciated by 69.99%, compared to the Sensex’s 16.51%. The five-year return of 134.68% dwarfs the Sensex’s 45.99%, while the ten-year gain of 544.77% far exceeds the benchmark’s 178.71%. These figures illustrate the company’s sustained growth trajectory and market leadership within the hospital sector — is this momentum sustainable or nearing a plateau?

Moving Average Configuration: Bullish Across All Key Timeframes

The technical setup for Apollo Hospitals Enterprise Ltd. is notably robust. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a strong upward trend across both short and long-term horizons. This configuration typically indicates sustained buying interest and a positive momentum backdrop.

Such a comprehensive bullish alignment across moving averages is relatively rare and suggests that the stock is in a confirmed uptrend rather than a transient bounce. This technical strength complements the fundamental performance, reinforcing the stock’s appeal within the hospital sector. However, the question remains — is this a trend continuation or a peak before consolidation?

Sector Context: Hospital Industry Showing Mixed but Generally Positive Results

The hospital sector has experienced a mixed performance recently, with some companies reporting flat or negative results while others have posted gains. Within this environment, Apollo Hospitals Enterprise Ltd. stands out as a consistent outperformer, reflecting its scale, diversified operations, and brand strength.

Sector valuations remain elevated, with an industry P/E of 66.24, reflecting investor optimism about healthcare demand and structural growth drivers. The sector’s mixed results highlight the importance of company-specific factors in driving stock performance — how does Apollo’s performance compare to its closest peers?

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously assigned a Hold rating to Apollo Hospitals Enterprise Ltd., with a Mojo Score of 75.0. The rating was updated on 11 May 2026, reflecting the company’s evolving fundamentals and market conditions. While the current rating is not disclosed, the reassessment underscores the dynamic nature of the stock’s profile amid changing valuation and performance metrics.

Investors may consider the implications of this rating update in light of the stock’s strong long-term returns and technical strength — should investors hold, buy more, or reconsider their position?

Conclusion: Data Reflects a Balanced Valuation with Strong Performance and Technical Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a valuation closely aligned with its sector peers. Its P/E ratio of 65.34 versus the industry’s 66.24 suggests neither a significant premium nor discount, indicating investor confidence in the company’s earnings quality and growth prospects.

Performance metrics reveal strong outperformance over multiple timeframes, particularly over the past year and longer horizons, with returns far exceeding the Sensex. The technical picture is equally encouraging, with the stock trading above all major moving averages, signalling a sustained uptrend.

Within a hospital sector showing mixed results, Apollo Hospitals Enterprise Ltd. remains a standout performer. The recent rating reassessment from a previous Hold rating reflects these evolving fundamentals and market dynamics — should investors in Apollo Hospitals hold, buy more, or reconsider?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today